Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Baxter

How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?

Baxter has notably underperformed the Medical Devices industry over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

What You Need To Know Ahead of Baxter International's Earnings Release

Baxter International is set to announce its fourth-quarter results soon, with analysts predicting a single-digit decline in the company's earnings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Wall Street Bullish or Bearish on Baxter International Stock?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Baxter Trims Annual Outlook Again, Stock Hits 52-Week

Baxter International Inc. (NYSE:BAX) stock hit a 52-week low on Thursday, after the company again lowered its 2025 guidance.

Benzinga

Is Baxter International Stock Underperforming the Dow?

Baxter International has considerably underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Baxter International Stock?

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously optimistic about its future potential.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook

Baxter International Inc. (NYSE:BAX) is down 19.4% at $22.66 at the last check on Thursday. At around 11 a.m. EST, shares of the medical device company traded at $21.68—just shy of its 52-week low.

Benzinga

Is Baxter International Stock Underperforming the Nasdaq?

Baxter International has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

What Are Wall Street Analysts' Target Price for Baxter International Stock?

Although Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Is Baxter International Stock Underperforming the S&P 500?

Despite its underperformance over the past year, Baxter International has notably outpaced the S&P 500 in the recent months and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Urgent recall for popular sandwich and burger ingredient over allergy fears

Food safety watchdogs say product could contain undeclared allergen

The Independent UK

Earnings Preview: What To Expect From Baxter International's Report

As Baxter International prepares to report its fourth-quarter earnings next month, analysts expect a double-digit profit dip.

Barchart

Wallpaper* Design Awards 2025: the best furniture and design objects for 2025

The Wallpaper* Design Awards 2025 present the best new furniture and interior accessories, while global design director Hugo Macdonald and head of interiors Olly Mason reveal what makes a winner

Wallpaper

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks?

Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects.

Barchart

Baxter International Stock: Analyst Estimates & Ratings

Due to Baxter International’s underperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

The Independent UK

Milton spares Daytona Beach, Florida, factory that's a critical supplier of IV fluids

A manufacturer of IV fluids critical to hospitals nationwide says its Florida factory and distribution center were left intact after Hurricane Milton tore through the state

Salon

Hospitals short on IV fluid after Helene

An IV fluid plant in North Carolina was hit by floodwaters and another now sits in the path of Hurricane Milton

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Hospitals across US reporting IV shortages after Hurricane Helene led to plant shutdown in NC

Hospitals are calling on the Biden administration to take urgent action, including declaring a national emergency

Wallpaper

Bruce Wayne’s furniture collection is moody, mysterious and Batman-approved (Batmobile not included)

Wayne Enterprises has curated a unique furniture collection inspired by Batman’s civilian persona. We find out what makes it all Bruce Wayne-worthy

Barchart

Baxter Stock: Is BAX Underperforming the Healthcare Sector?

Baxter has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

StockNews.com

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

Barchart

Do Wall Street Analysts Like Baxter International Stock?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's prospects.

StockNews.com

3 Growth Stocks With P/E Ratios Below Industry Average

Growth stocks trading at lower P/E ratio than the industry average can be a suitable investment choice. Top picks now could be Cardinal Health (CAH), Baxter International (BAX), and DocuSign (DOCU). Keep reading.

The Guardian - UK

Infected blood scandal: call for drug firms to pay part of £10bn compensation

‘Outrageous’ that payouts to victims in other countries are not being matched in UK, say campaigners

1 2

People

Michael Anastassiades

15 stories

Carlo Scarpa

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food Standards Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.